Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials
about
Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@ast
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@en
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@nl
type
label
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@ast
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@en
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@nl
prefLabel
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@ast
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@en
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@nl
P2093
P2860
P1476
Desipramine, substrate for CYP ...... f drug-drug interaction trials
@en
P2093
Ivelina Gueorguieva
Jenny Y Chien
Kimberley Jackson
Steven A Wrighton
Vikram P Sinha
P2860
P304
P356
10.1111/J.1365-2125.2010.03731.X
P407
P577
2010-10-01T00:00:00Z